Diminished vaginal HOXA13 expression in women with pelvic organ prolapse

Menopause

Volumn 16, Issue 3, 2009, Pages 529-533

  Connell, Kathleen A ^a   Guess, Marsha K ^a   Tate, Alison ^a   Andikyan, Vaagn ^a   Bercik, Richard ^a   Taylor, Hugh S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen.; Homeobox genes; HOXA13; Pelvic organ prolapse; Vagina

Indexed keywords

ESTROGEN; LEUPRORELIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA13; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOPSY; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VAGINA;

ADULT; CASE-CONTROL STUDIES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MIDDLE AGED; UTERINE PROLAPSE; VAGINA;

EID: 67649866351     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31818fb0c2     Document Type: Article

References (37)

1. Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse. Lancet 2007;369:1027-1038.
2. Samuelsson EC, Victor FT, Tibblin G, Svardsudd K. Signs of genital prolapse in a Swedish population of women 20-59 years of age and possible related factors. Am J Obstet Gynecol 1999;180:299-305.
3. Drutz H, Alarab M. Pelvic organ prolapse: demographics and future growth prospects. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:S6-S9.
4. Olsen AL, Smith VJ, Berstrom JO, Colling JC, Clark A. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-506.
5. Swift SE, Pound T, Dias JK. Case-control study of etiologic factors in the development of severe pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:187-192.
6. Kim CM, Jeon MJ, Chung DJ, Kim SK, Kim JW, Bai SW. Risk factors for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2007;98:248-251.
7. Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007;109: 1396-1403.
8. Boreham MK, Wai CY, Miller RT, Schaffer JI, Word RA. Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 2002;187:56-63.
9. Jackson SR, Avery NXC, Rarlton JF, et al. Changes in the metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658-1661.
10. Liapis A, Bakas P, Pafiti A, et al. Changes in collagen type III in female patients with genuine stress incontinence and pelvic floor prolapse. Eur J Obstet Gynecol Reprod Biol 2001;9776-9779.
11. Makinen J, Kahari VM, Soderstrom KO, et al. Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse. Eur J Obstet Gynecol Reprod Biol 1987;24:319-325.
12. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:80-87.
13. Takano CC, Girao MJ, Sartori MG, et al. Analysis of collagen in parametrium and vaginal apex of women with pelvic organ prolapse. Int J Urogynecology Pelvic Floor Dysfunct 2002;13:342-345.
14. Connell KA, Guess MK, Chen H, Andikyan V, Bercik R, Taylor HS. HOXA11 is critical for development and maintenance of uterosa-cral ligaments and deficient in pelvic prolapse. J Clin Invest 2008;118: 1050-1055.
15. Stevenson SJ, Nelson LD, Sharpe DT, Thornton MJ. 17β-Estradiol regulates the secretion of TGF-β by cultured human dermal fibroblasts. Biomater Sci Polymed 2008;19:1097-1109.
16. Zbucka M, Miltyk W, Bielawski T, Surazynski A, Palka J, Wolczynski S. Mechanism of collagen biosynthesis up-regulation in cultured leio-myoma cells. Folia Histochem Cytobiol 2007;45:S181-S185.
17. Tizk DEE, Hassan HA, Al-Marzouqi AH, et al. Combined estrogen and ghrelin administration restores number of blood vessels and collagen type I/III ratio in the urethral and anal canal submucosa of old ovariectomized rats. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:547-552.
18. Markiewicz M, Asano Y, Znoyko S, Gong Y, Watson DK, Trojanowska M. Distinct effects of gonadectomy in male and female mice on collagen fibrillogenesis in the skin. J Dermatol Sci 2007;47:217-226.
19. Moalli PA, Talarco LC, Sung VW, et al. Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis. Am J Obstet Gynecol 2004;190:620-627.
20. Moalli PA, Debes KM, Meyn LA, Howden NS, Abramowitch SD. Hormones restore biomechanical properties of the vagina and supportive tissues after surgical menopause in young rats. Am J Obstet Gynecol 2008;199:161,e1-161,e8.
21. Taylor HS, Vanden Heuvel GB, Igarashi P. A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the HOXA cluster genes. Biol Reprod 1997;57:1338-1345.
22. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human en-dometrium. J Clin Invest 1998;101:1379-1384.
23. Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. J Clin Endocrinol Metab 1999;84:1129-1135.
24. Utsch B, McCabe CD, Galbraith K, et al. Molecular characterization of HOXA13 polyalanine expansion proteins in hand-foot-genital syndrome. J Med Genet 2007;143A:3161-3168.
25. Frisén L, Lagerstedt K, Tapper-Persson M, Kockum I, Nordenskjöld A. A novel duplication in the HOXA13 gene in a family with atypical hand-foot-genital syndrome. J Med Genet 2003;40:e49.
26. Goodman FR, Bacchelli C, Brady AF, et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000;67:197-202.
27. Mortlock DP, Innis JW. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 1997;15:179-180.
28. Vitiello D, Pinard R, Taylor HS. Gene expression profiling reveals putative HOXA10 downstream targets in the periimplantation mouse uterus. Reprod Sci 2008;15:529-535.
29. Williams TM, Williams ME, Kuick R, et al. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability. Dev Biol 2005;279:462-480.
30. Bump RC, Mattiasson A, Bo K, Brubaker LP, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 1996;175:10-17.
31. Drewes PG, Yanagisawa H, Starcher B, et al. Pelvic organ prolapse in fibulin-5 knockout mice: pregnancy-induced changes in elastic fiber homeostasis in mouse vagina. Am J Pathol 2007;170:578-589.
32. Kielty CM. Elastic fibres in health and disease. Expert Rev Mol Med 2006;8:1-23.
33. Carley ME, Schaffer J. Urinary incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos syndrome. Am J Obstet Gynecol 2000;182:1021-1023.
34. Tzu J, Marinkovich MP. Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol 2008;40:199-214.
35. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001;107:1049-1054.
36. Barker TH, Baneyx G, Cardó-Vila M, et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 2005;280:36483-36493.
37. Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293: 935-948.